Melanoma
Conference Coverage
Mohs surgery in the elderly: The dilemma of when to treat
“The take-home point for me is to treat your whole patient, not just the tumor.”
Conference Coverage
Bupivacaine following Mohs surgery reduces opioid use, study finds
Recent research has shown that Mohs micrographic surgeons have the highest rates of opioid prescribing of all dermatologists.
News
Experts urge stopping melanoma trial because of failure and harm
Immunotherapy combo fails in BRAF V60–mutated melanoma. Results suggest its time to abandon combination of PD-1/PD-L1 inhibitors with BRAF and MEK...
Opinion
Dodging potholes from cancer care to hospice transitions
The consequences of suboptimal hospice transitions can damage the mental health and well-being of patient and caregiver.
News
Q&A with Hubert (Hugh) Greenway, MD
“Every patient who comes to see me has a story, so I try to understand their story,” Dr. Hugh Greenway said.
Conference Coverage
Which solid organ transplant recipients face the highest risk of skin cancer?
Those at low risk for skin cancer include abdominal organ recipients, SOTR age of younger than 50 at time of transplant, and female gender.
News
Age, skin cancer risks for ICI-induced bullous pemphigoid identified
“It’s harder to understand why a presumably antibody-mediated side effect would be more likely to have that cross-reactivity where the tumor...
Conference Coverage
Made-to-order TILs effective against metastatic melanoma
The product, called lifileucel, is custom made for each patient.
News
Study finds discrepancies in biopsy decisions, diagnoses based on skin type
Disparities in dermatologic care among Black patients, compared with White patients, have been well documented.
News
Global melanoma incidence high and on the rise
The highest incidence and mortality rates of cutaneous melanoma are in wealthy nations, a new study shows.
